Rapid recovery of CD3+CD8+ T cells on day 90 predicts superior survival after unmanipulated haploidentical blood and marrow transplantation

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Tian, Deng Mei ^a,d   Wang, Yu ^a   Zhang, Xiao Hui ^a   Liu, Kai Yan ^a   Huang, Xiao Jun ^a,b,c   Chang, Ying Jun ^a,c  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b Tsinghua University   (China)

^c PEKING UNIVERSITY   (China)

^d 309TH HOSPITAL OF PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; BLOOD SAMPLING; BONE MARROW TRANSPLANTATION; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE FREE SURVIVAL; FEMALE; HAPLOIDENTICAL BLOOD AND MARROW TRANSPLANTATION; HELPER CELL; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; LEUKEMIA FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON RELAPSE MORTALITY; OVERALL SURVIVAL; SURVIVAL PREDICTION; TREATMENT OUTCOME; ALLOGRAFT; BLOOD; CLINICAL TRIAL; CONVALESCENCE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LEUKEMIA; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; PRESCHOOL CHILD; SURVIVAL RATE;

ADOLESCENT; ADULT; ALLOGRAFTS; BONE MARROW TRANSPLANTATION; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; SURVIVAL RATE; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84974802638     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156777     Document Type: Article

References (35)

1. Seggewiss R, Einsele H. Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update. Blood. 2010; 115(19):3861-3868. doi: 10.1182/blood-2009-12-234096 PMID: 20215642
2. Bosch M, Khan FM, Storek J. Immune reconstitution after hematopoietic cell transplantation. Curr Opin Hematol. 2012; 19(4):324-335. doi: 10.1097/MOH.0b013e328353bc7d PMID: 22517587
3. Bleakley M, Riddell SR. Molecules and mechanisms of the graft-versus-leukaemia effect. Nat Rev Cancer. 2004; 4(5):371-380. PMID: 15122208
4. Ishaqi MK, Afzal S, Dupuis A, Doyle J, Gassas A. Early lymphocyte recovery post-allogeneic hematopoietic stem cell transplantation is associated with significant graft-versus-leukemia effect without increase in graft-versus-host disease in pediatric acute lymphoblastic leukemia. Bone Marrow Transplant. 2008; 41(3):245-252. PMID: 17952129
5. Le Blanc K, Barrett AJ, Schaffer M, Hägglund H, Ljungman P, Ringdén O, et al. Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies. Biol Blood Marrow Transplant. 2009; 15(9):1108-1115. doi: 10.1016/j.bbmt.2009.05.015 PMID: 19660724
6. Savani BN, Mielke S, Rezvani K, Montero A, Yong AS, Wish L, et al. Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2007; 13(10):1216-1223. PMID: 17889359
7. Savani BN, Mielke S, Adams S, Uribe M, Rezvani K, Yong AS, et al. Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia. Leukemia. 2007; 21(10):2145-2152. PMID: 17673900
8. Koehl U, Bochennek K, Zimmermann SY, Lehrnbecher T, Sörensen J, Esser R, et al. Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+CD3+ count reconstitution is associated with survival. Bone Marrow Transplant. 2007; 39(5):269-278. PMID: 17311085
9. Merindol N, Champagne MA, Duval M, Soudeyns H. CD8(+) T-cell reconstitution in recipients of umbilical cord blood transplantation and characteristics associated with leukemic relapse. Blood. 2011; 118(16):4480-4488. doi: 10.1182/blood-2011-04-349241 PMID: 21813446
10. Parkman R, Cohen G, Carter SL, Weinberg KI, Masinsin B, Guinan E, et al. Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation. Biol Blood Marrow Transplant. 2006; 12(9):919-927. PMID: 16920557
11. Berger M, Figari O, Bruno B, Raiola A, Dominietto A, Fiorone M, et al. Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality. Bone Marrow Transplant. 2008; 41(1):55-62. PMID: 17934532
12. Kim DH, Sohn SK, Won DI, Lee NY, Suh JS, Lee KB. Rapid helper T-cell recovery above 200 x 106/L at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation. Bone Marrow Transplant. 2006; 37(12):1119-1128. PMID: 16699530
13. Wang Y, Liu DH, Liu KY, Xu LP, Zhang XH, Han W, et al. Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center. Cancer. 2013; 119(5):978-985. doi: 10.1002/cncr.27761 PMID: 23097265
14. Chang YJ, Zhao XY, Huo MR, Xu LP, Liu DH, Liu KY, et al. Immune reconstitution following unmanipulated HLA-mismatched/haploidentical transplantation compared with HLA-identical sibling transplantation. J Clin Immunol. 2012; 32(2):268-280. doi: 10.1007/s10875-011-9630-7 PMID: 22173879
15. Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, et al. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant. 2006; 38(4):291-297. PMID: 16883312
16. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993; 329(14):987-994. PMID: 8141877
17. Lu DP, Dong L, Wu T, Huang XJ, Zhang MJ, Han W, et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood. 2006; 107(8):3065-3073. PMID: 16380454
18. Chang YJ, Zhao XY, Huo MR, Xu LP, Liu DH, Liu KY, et al. Clinical impact of absolute lymphocyte count on day 30 after unmanipulated haploidentical blood and marrow transplantation for pediatric patients with hematological malignancies. Am J Hematol. 2011; 86(2):227-230. doi: 10.1002/ajh.21921 PMID: 21264916
19. Yan CH, Liu DH, Liu KY, Xu LP, Liu YR, Chen H, et al. Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation.Blood. 2012; 119(14):3256-3262. doi: 10.1182/blood-2011-09-380386 PMID: 22337715
20. Oliver BG, Elliott JH, Price P, Phillips M, Saphonn V, Vun MC, et al. Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy. J Infect Dis. 2010; 202(11):1728-1737. doi: 10.1086/657082 PMID: 20977362
21. Fedele R, Martino M, Garreffa C, Messina G, Console G, Princi D, et al. The impact of early CD4+ lymphocyte recovery on the outcome of patients who undergo allogeneic bone marrow or peripheral blood stem cell transplantation. Blood Transfus. 2012; 10(2):174-180. doi: 10.2450/2012.0034-11 PMID: 22337266
22. Kmieciak M, Payne KK, Wang XY, Manjili MH. IFN-γ Rα is a key determinant of CD8+ T cell-mediated tumor elimination or tumor escape and relapse in FVB mouse. PLoS One. 2013; 8(12):e82544. doi: 10.1371/journal.pone.0082544 PMID: 24324806
23. +T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. Blood. 2012; 119(4):967-977. doi: 10.1182/blood-2011-06-362582 PMID: 22147891
24. Pantaleo G, Harari A. Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat Rev Immunol. 2006; 6(5):417-423. PMID: 16622477
25. Luo XH, Huang XJ, Liu KY, Xu LP, Liu DH. Protective immunity transferred by infusion of cytomegalovirus-specific CD8(+) T cells within donor grafts: its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2010; 16(7):994-1004. doi: 10.1016/j.bbmt.2010.02.007 PMID: 20167279
26. +T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A. 2005; 102(27):9571-9576. PMID: 15980149
27. Goldrath AW, Luckey CJ, Park R, Benoist C, Mathis D. The molecular program induced in T cells undergoing homeostatic proliferation. Proc Natl Acad Sci U S A. 2004; 101(48):16885-16890. PMID: 15548615
28. Politikos I, Boussiotis VA. The role of the thymus in T-cell immune reconstitution after umbilical cord blood transplantation.Blood. 2014; 124(22):3201-3211. doi: 10.1182/blood-2014-07-589176 PMID: 25287708
29. Oghumu S, Terrazas CA, Varikuti S, Kimble J, Vadia S, Yu L, Seveau S, et al. CXCR3 expression defines a novel subset of innate CD8+ T cells that enhance immunity against bacterial infection and cancer upon stimulation with IL-15. FASEB J. 2015; 29(3):1019-1028. doi: 10.1096/fj.14-264507 PMID: 25466888
30. + T cells in response to infection is markedly efficient. Science. 2009; 325(5945):1265-1269. doi: 10.1126/science.1175455 PMID: 19729659
31. Ding ZC, Huang L, Blazar BR, Yagita H, Mellor AL, Munn DH, et al. Polyfunctional CD4+ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy. Blood. 2012; 120(11):2229-2239. doi: 10.1182/blood-2011-12-398321 PMID: 22859605
32. Chang YJ, Zhao XY, Huang XJ. Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies. Biol Blood Marrow Transplant. 2008; 14(3):323-334. doi: 10.1016/j.bbmt.2007.12.497 PMID: 18275899
33. Dong L, Wu T, Zhang MJ, Gao ZY, Lu DP. CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin. Biol Blood Marrow Transplant. 2007; 13(12):1515-1524. PMID: 18022582
34. Chang YJ, Zhao XY, Xu LP, Liu DH, Liu KY, Chen YH, et al. Early lymphocyte recovery predicts superior overall survival after unmanipulated haploidentical blood and marrow transplant for myelodysplastic syndrome and acute myeloid leukemia evolving from myelodysplastic syndrome. Leuk Lymphoma. 2013; 54(12):2671-2677. doi: 10.3109/10428194.2013.783912 PMID: 23550991
35. Chang YJ, Zhao XY, Huo MR, Xu LP, Liu DH, Liu KY, et al. Influence of lymphocyte recovery on outcome of haploidentical transplantation for hematologic malignancies. Medicine (Baltimore). 2009; 88(6):322-330.